EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of alkylator resistant chronic lymphocytic leukemia with oral fludarabine phosphate



Treatment of alkylator resistant chronic lymphocytic leukemia with oral fludarabine phosphate



Blood 94(10 SUPPL 1 PART 1): 704a, Nov 15




(PDF 0-2 workdays service: $29.90)

Accession: 035980902

Download citation: RISBibTeXText



Related references

Oral Fludarabine Phosphate as First-Line Treatment of Chronic Lymphocytic Leukemia. Blood 100(11): Abstract No 1491, November 16, 2002

Second malignancies in B-cell chronic lymphocytic leukemia Association with CLL but no additional impact with fludarabine or alkylator treatment. Blood 94(10 SUPPL 1 PART 2): 298b, Nov 15, 1999

Treatment of a de novo fludarabine resistant chronic lymphocytic leukemia model with bryostatin 1 followed by fludarabine. Blood 92(10 SUPPL 1 PART 1-2): 597A, Nov 15, 1998

Activity of oral fludarabine phosphate in previously treated chronic lymphocytic leukemia. Journal of Clinical Oncology 19(22): 4252-4258, 2001

Fludarabine phosphate in the treatment of chronic lymphocytic leukemia. Seminars in Oncology 17(5 Suppl 8): 49-62, 1990

Fludarabine in comparison to alkylator-based regimen as induction therapy for chronic lymphocytic leukemia: a systematic review and meta-analysis. Leukemia & Lymphoma 45(11): 2239-2245, 2004

Efficacy and safety of oral fludarabine phosphate in previously untreated patients with chronic lymphocytic leukemia. Journal of Clinical Oncology 22(7): 1260-1267, 2004

The use of fludarabine phosphate (Fludara) to treat chronic B-cell lymphocytic leukemia and non-Hodgkin's lymphoma resistant to standard chemotherapy. Voprosy Onkologii 44(6): 696-700, 1999

Fludarabine phosphate in the treatment of advanced-stage chronic lymphocytic leukemia. Annals of Hematology 67(SUPPL ): A49, 1993

Application of fludarabine phosphate (Fludara) to treat B-cell chronic lymphocytic leukemia and non-Hodgkin's lymphoma resistant to standard chemotherapy. Voprosy Onkologii (Stsburg). 1998; 44(6): 696-700, 1998

Successful treatment for advanced and refractory chronic lymphocytic leukemia with fludarabine phosphate. Japanese Journal of Clinical Hematology 38(9): 792-794, 1997

Tumor lysis syndrome complicating treatment of chronic lymphocytic leukemia with fludarabine phosphate. American Journal of Medicine 89(3): 388-390, 1990

Pharmacokinetic study of single doses of oral fludarabine phosphate in patients with "low-grade" non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia. Journal of Clinical Oncology 17(5): 1574-1579, 1999

Progressive multifocal leukoencephalopathy following oral fludarabine treatment of chronic lymphocytic leukemia. Annals of Hematology 79(7): 392-395, July, 2000

Fludarabine phosphate in the treatment of chronic lymphocytic leukemia: biology, clinical impact, and future directions. Cancer Treatment and Research 64: 105-119, 1993